• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Flora Growth Corp. Announces First Purchase of 0G, the Fuel of the 0G Decentralized AI Network

    10/8/25 8:00:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FLGC alert in real time by email

    Fort Lauderdale, Florida--(Newsfile Corp. - October 8, 2025) - Flora Growth Corp. (NASDAQ:FLGC) (the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G"), today announced the purchase of 772,200 0G at an average price of $2.59. The purchase represents the Company's first acquisition of 0G since its most recent $401 million fundraising and strategic shift to build the world's first publicly listed 0G treasury.

    Below is a summary of the Company's current 0G position and key per-share metrics as of October 6, 2025:

    • Total 0G held: 122,538,335 tokens
    • Total 0G equivalents held(1) (USD): Approximately $352 million(2)
    • Partially adjusted total common shares outstanding(3): 9,809,754 shares
    • 0G per share ("ZGPS")(4): 12.491
    • ZGPS (USD)(5): $35.85

    All newly purchased 0G are expected to be held long-term and staked to generate native yield.

    (1) “Total 0G equivalents held” refers 0G tokens for which the Company has a contractual right to obtain, subject to the satisfaction of certain conditions.
    (2) Based on a 0G value of US$2.87 per token (the “0G Value”), which was the closing price of 0g on Binance on October 7, 2025.
    (3) The “partially adjusted total common shares outstanding” figure reflects the issued and outstanding shares as of today and (i) includes common shares issuable upon exercise of pre-funded warrants and warrants and (ii) excludes common shares issuable upon conversion of convertible notes (the “Note Shares”), in each case, pursuant to the transactions announced September 19, 2025. Including all Note Shares, the adjusted total common shares outstanding would be approximately 14,985,796.
    (4) Calculated as Total 0G held divided by partially adjusted total common shares outstanding.
    (5) Calculated as Total 0G held multiplied by the 0G Value and divided by partially adjusted total common shares outstanding. ZGPS will fully reflect the issuance of the Note Shares in future updates if and as issued, alongside the deployment of the remaining cash proceeds from the transactions announced September 19, 2025 into additional 0G purchases.

    "This initial 0G purchase represents an important milestone in the Company's mission to become the go-to public vehicle for Decentralized AI exposure," said Daniel Reis-Faria, incoming CEO of the Company. "It also marks the beginning of a long journey where we intend to push the limits of 0G adoption and fuel the success of Decentralized AI."

    The Company's evolving treasury strategy aligns with its broader vision of bridging traditional investors to the Decentralized AI economy by creating a regulated, transparent, and accessible pathway to 0G, the native token of the 0G Network. The 0G Network is the one of the largest AI-first blockchain that is infinitely scalable and designed to power the future of distributed AI.

    About Flora Growth Corp.:
    Flora Growth Corp., which is set to be rebranded as ZeroStack, is the first and largest decentralized AI treasury company that is investing in the future of AI infrastructure through strategic ownership in 0G, an AI infrastructure company that has created an open and decentralized AI network fueled by the 0G token. The Company is a global pharmaceutical distributor through its wholly owned subsidiary Phatebo GmbH. For more information, visit https://zerostack.ai/.

    Forward-Looking Statements
    This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," strategy," "future," "likely," "may,", "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations, and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) fluctuations in the market price of 0G and any associated impairment charges that the Company may incur as a result of a decrease in the market price of 0G below the value at which the Company's 0G are carried on its balance sheet; (ii) volatility in our share price, including due to future issuances of common shares and securities convertible into common shares; (iii) the effect of and uncertainties related the ongoing volatility in interest rates; (iv) our ability to achieve and maintain profitability in the future; (v) the impact on our business of the regulatory environment and complexities with compliance related to such environment including changes in securities laws or other laws or regulations; (vi) changes in the accounting treatment relating to the Company's 0G holdings; (vii) our ability to respond to general economic conditions; (viii) our ability to manage our growth effectively and our expectations regarding the development and expansion of our business; (ix) our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth and (x) other risks and uncertainties more fully in the section captioned "Risk Factors" in the Company's most recent Annual Report on Form 10-K and other reports and/or registration statements we file with the SEC. As a result of these matters, changes in facts, assumptions not being realized, or other circumstances, the Company's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

    Investor Contact: [email protected]

    Media Contact: [email protected]

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/269575

    Get the next $FLGC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FLGC

    DatePrice TargetRatingAnalyst
    11/25/2024$4.00Buy
    Aegis Capital
    10/13/2021$10.00Buy
    Roth Capital
    6/23/2021$6.00Buy
    MKM Partners
    More analyst ratings

    $FLGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Flora Growth Corp. Announces First Purchase of 0G, the Fuel of the 0G Decentralized AI Network

    Fort Lauderdale, Florida--(Newsfile Corp. - October 8, 2025) - Flora Growth Corp. (NASDAQ:FLGC) (the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G"), today announced the purchase of 772,200 0G at an average price of $2.59. The purchase represents the Company's first acquisition of 0G since its most recent $401 million fundraising and strategic shift to build the world's first publicly listed 0G treasury.Below is a summary of the Company's current 0G position and key per-share metrics as of October 6, 2025:Tot

    10/8/25 8:00:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DeFi Development Corp. Announces Strategic Collaboration with ZeroStack in Treasury Accelerator Deal

    BOCA RATON, FL , Sept. 22, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company") the first public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced a strategic collaboration with ZeroStack, a next-generation Digital Asset Treasury (DAT) focused on accumulating the 0G cryptoasset. 0G is the native token behind the 0G Network, a decentralized AI Layer-1 blockchain that orchestrates hardware resources and software assets to handle AI workloads at scale. As part of the relationship, the Company participated in a private placement transaction by Flora Growth Corp. (NASDAQ:FLGC), which expects to rebrand as ZeroStack, throu

    9/22/25 5:00:00 AM ET
    $DFDV
    $FLGC
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth Corp. (FLGC) Announces $401 Million Funding with a $22.88 Million Strategic Investment from Defi Development Corp. (DFDV) to Initiate Groundbreaking AI Zero Gravity ($0G) Coin Treasury Strategy

    $0G, the native cryptocurrency of the distributed AI infrastructure project 0G, will serve as the company's primary reserve assetPartners include DeFi Dev Corp., the first digital asset treasury company to accumulate and compound SolanaFlora to rebrand as ZeroStack and appoint 0G's Co-Founder, Michael Heinrich, to the role of Executive Chairman and Daniel Reis-Faria as CEO$0G is the first-to-market AI-based Digital Asset TreasuryFort Lauderdale, Florida--(Newsfile Corp. - September 19, 2025) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") today announced the pricing of a private investment in public equity offering, positioning the Company to implement a 0G treasury strategy. 0

    9/19/25 6:53:00 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    SEC Filings

    View All

    Flora Growth Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Flora Growth Corp. (0001790169) (Filer)

    9/29/25 5:18:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Flora Growth Corp.

    424B5 - Flora Growth Corp. (0001790169) (Filer)

    9/29/25 5:10:59 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Flora Growth Corp. (0001790169) (Filer)

    9/23/25 8:28:12 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Starke Clifford bought $6,455 worth of shares (6,795 units at $0.95), increasing direct ownership by 13,324% to 6,846 units (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/17/24 10:17:39 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Wolkin Harold bought $24,255 worth of shares (25,000 units at $0.97) (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/11/24 5:43:51 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Starke Clifford bought $48 worth of shares (51 units at $0.95), increasing direct ownership by 0.01% to 474,046 units (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/6/24 5:25:10 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Reis-Faria Daniel

    3 - Flora Growth Corp. (0001790169) (Issuer)

    10/6/25 5:09:14 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Wolkin Harold

    4 - Flora Growth Corp. (0001790169) (Issuer)

    7/2/25 11:04:19 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Leventhal Manfred

    4 - Flora Growth Corp. (0001790169) (Issuer)

    7/2/25 10:56:28 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aegis Capital initiated coverage on Flora Growth with a new price target

    Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00

    11/25/24 8:07:10 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roth Capital initiated coverage on Flora Growth with a new price target

    Roth Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $10.00

    10/13/21 9:00:51 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MKM Partners initiated coverage on Flora Growth with a new price target

    MKM Partners initiated coverage of Flora Growth with a rating of Buy and set a new price target of $6.00

    6/23/21 5:36:01 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    Financials

    Live finance-specific insights

    View All

    Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday, November 28 at 4:30 p.m. ET. During the webcast, Flora management will deliver financial and operational results for the third quarter ended September 30, 2022, and provide updates on Flora's commercial wholesale operations, house of brands and life sciences division strategies. Following the webcast, Flora management will open the call to analysts, media and investors in a Q&A format. Live Webcast Details Date: Monday, November 28, 2022 Time: 4:30 p.m. ET

    11/21/22 7:05:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that the Company will be hosting an analyst call on Wednesday, October 26, 2022, at 02:00 p.m. EST via webcast to discuss Flora Growth's recent M&A activity and strategic growth opportunities. The conference call and live webcast will invite analysts to pose questions to Flora and Franchise Global Health's leadership teams regarding the recent announcement of the definitive agreement of acquisition between the two companies and the opportunities within the cannabis industry on the global stage. To access this ca

    10/25/22 7:05:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth Awarded Best M&A Deal at Benzinga Cannabis Capital Conference

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that the Company received the Best M&A Deal award at Benzinga's 2022 Cannabis Capital Conference in Chicago. "We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers," said Luis Merchan, Chairman and CEO of Flora. Flora completed the acquisition of JustCBD in February 2022, and it immediately offered the Company an established CPG brand with a por

    9/13/22 7:05:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    Leadership Updates

    Live Leadership Updates

    View All

    Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid Requirement

    Fort Lauderdale, Florida--(Newsfile Corp. - June 27, 2023) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, announced today that Clifford Starke has been appointed as Chief Executive Officer to lead its global operations and Dany Vaiman has been appointed as Chief Financial Officer. Mr. Starke, who previously served as President of the Company, takes over for Hussein Rakine, who resigned as CEO but will remain on the Company's Board of Directors. Mr. Rakine expressed his confidence in the appointment, stating, "Clifford's

    6/27/23 4:05:00 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors

    Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the "Board") accepted the resignation of Luis Merchan as Chairman of the Board and the Company's Chief Executive Officer (CEO). To fill the vacancies created by Mr. Merchan's resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member of the board of directors. Of the appointment, former-Chairman and CEO, Luis Merchan said, "At Flora we have consistently placed human capital as a critical part of our M&A strategy. That's why today we are honored to have the former foun

    4/18/23 4:05:00 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CBD Oil Market to Hit Nearly US$137 Billion by 2029

    FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Aug. 23, 2022 /PRNewswire/ -- The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing number of CBD-infused skincare products, increased use of THC and CBD in pain management and treatment, rising sales in both retail stores and online, expanding research, and increasing demand for ingestible products. Governments around the world have also begun opening up more doors for CBD, with a recent Health Canada report suggesting legal framework to broaden retail CBD sales across

    8/23/22 8:50:00 AM ET
    $CGC
    $CRON
    $FLGC
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $FLGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Flora Growth Corp.

    SC 13G/A - Flora Growth Corp. (0001790169) (Subject)

    11/14/24 2:24:54 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care